INTRODUCTION: The minimal stroke severity justifying endovascular intervention remains elusive; however, a significant proportion of patients presenting with large vessel occlusion (LVO) and mild symptoms subsequently decline and face poor outcomes. OBJECTIVE: To evaluate our experience with these patients by comparing best medical therapy with thrombectomy in an intention-to-treat analysis. METHODS: Analysis of prospectively collected data of all consecutive patients with National Institutes of Health Stroke Scale (NIHSS) score ≤5, LVO on CT angiography, and baseline modified Rankin Scale (mRS) score 0-2 from November 2014 to May 2016. After careful discussion with patients/family, a decision to pursue medical or interventional therapy was made. Deterioration (development of aphasia, neglect, and/or significant weakness) triggered reconsideration of thrombectomy. The primary outcome measure was NIHSS shift (discharge NIHSS score minus admission NIHSS score). RESULTS: Of the 32 patients qualifying for the study, 22 (69%) were primarily treated with medical therapy and 10 (31%) intervention. Baseline characteristics were comparable. Nine (41%) medically treated patients had subsequent deterioration requiring thrombectomy. Median time from arrival to deterioration was 5.2 hours (2.0-25.0). Successful reperfusion (modified Treatment in Cerebral Infarction 2b-3) was achieved in all 19 thrombectomy patients. The NIHSS shift significantly favored thrombectomy (-2.5 vs 0; p<0.01). The median NIHSS score at discharge was low with both thrombectomy (1 (0-3)) and medical therapy (2 (0.5-4.5)). 90-Day mRS 0-2 rates were 100% and 77%, respectively (p=0.15). Multivariable linear regression indicated that thrombectomy was independently associated with a beneficial NIHSS shift (unstandardized β -4.2 (95% CI -8.2 to -0.1); p=0.04). CONCLUSIONS: Thrombectomy led to a shift towards a lower NIHSS in patients with LVO presenting with minimal stroke symptoms. Despite the overall perception that this condition is benign, nearly a quarter of patients primarily treated with medical therapy did not achieve independence at 90 days. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
INTRODUCTION: The minimal stroke severity justifying endovascular intervention remains elusive; however, a significant proportion of patients presenting with large vessel occlusion (LVO) and mild symptoms subsequently decline and face poor outcomes. OBJECTIVE: To evaluate our experience with these patients by comparing best medical therapy with thrombectomy in an intention-to-treat analysis. METHODS: Analysis of prospectively collected data of all consecutive patients with National Institutes of Health Stroke Scale (NIHSS) score ≤5, LVO on CT angiography, and baseline modified Rankin Scale (mRS) score 0-2 from November 2014 to May 2016. After careful discussion with patients/family, a decision to pursue medical or interventional therapy was made. Deterioration (development of aphasia, neglect, and/or significant weakness) triggered reconsideration of thrombectomy. The primary outcome measure was NIHSS shift (discharge NIHSS score minus admission NIHSS score). RESULTS: Of the 32 patients qualifying for the study, 22 (69%) were primarily treated with medical therapy and 10 (31%) intervention. Baseline characteristics were comparable. Nine (41%) medically treated patients had subsequent deterioration requiring thrombectomy. Median time from arrival to deterioration was 5.2 hours (2.0-25.0). Successful reperfusion (modified Treatment in Cerebral Infarction 2b-3) was achieved in all 19 thrombectomy patients. The NIHSS shift significantly favored thrombectomy (-2.5 vs 0; p<0.01). The median NIHSS score at discharge was low with both thrombectomy (1 (0-3)) and medical therapy (2 (0.5-4.5)). 90-Day mRS 0-2 rates were 100% and 77%, respectively (p=0.15). Multivariable linear regression indicated that thrombectomy was independently associated with a beneficial NIHSS shift (unstandardized β -4.2 (95% CI -8.2 to -0.1); p=0.04). CONCLUSIONS: Thrombectomy led to a shift towards a lower NIHSS in patients with LVO presenting with minimal stroke symptoms. Despite the overall perception that this condition is benign, nearly a quarter of patients primarily treated with medical therapy did not achieve independence at 90 days. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Negar Asdaghi; Dileep R Yavagal; Kefeng Wang; Nils Mueller-Kronast; Nirav Bhatt; Hannah E Gardener; Carolina M Gutierrez; Erika Marulanda-Londoño; Sebastian Koch; Chuanhui Dong; Sophia A Oluwole; Ricardo Hanel; Brijesh Mehta; Mary Robichaux; Ulises Nobo; Juan C Zevallos; Tatjana Rundek; Ralph L Sacco; Jose G Romano Journal: Stroke Date: 2019-07-15 Impact factor: 7.914
Authors: Amrou Sarraj; Ameer Hassan; Sean I Savitz; James C Grotta; Chunyan Cai; Kaushik N Parsha; Christine M Farrell; Bita Imam; Clark W Sitton; Sujan T Reddy; Haris Kamal; Nitin Goyal; Lucas Elijovich; Katelin Reishus; Rashi Krishnan; Navdeep Sangha; Abel Wu; Renata Costa; Ruqayyah Malik; Osman Mir; Rashedul Hasan; Lindsay M Snodgrass; Manuel Requena; Dion Graybeal; Michael Abraham; Michael Chen; Louise D McCullough; Marc Ribo Journal: Stroke Date: 2018-10 Impact factor: 7.914
Authors: Nitin Goyal; Georgios Tsivgoulis; Konark Malhotra; Muhammad F Ishfaq; Abhi Pandhi; Michael T Frohler; Alejandro M Spiotta; Mohammad Anadani; Marios Psychogios; Volker Maus; Adnan Siddiqui; Muhammad Waqas; Peter D Schellinger; Marcel Groen; Christos Krogias; Daniel Richter; Maher Saqqur; Pablo Garcia-Bermejo; Maxim Mokin; Ronen Leker; Jose E Cohen; Aristeidis H Katsanos; Georgios Magoufis; Klearchos Psychogios; Vasileios Lioutas; Meg VanNostrand; Vijay K Sharma; Maurizio Paciaroni; Alexandros Rentzos; Hazem Shoirah; J Mocco; Christopher Nickele; Violiza Inoa; Daniel Hoit; Lucas Elijovich; Andrei V Alexandrov; Adam S Arthur Journal: JAMA Neurol Date: 2020-01-01 Impact factor: 18.302
Authors: Wang Dongmei; Hao Peng; Wang Mengyao; Lin Zhenzhou; Zhou Liang; Fan Zusen; Pan Yue; Zhang Xiaomei; Pan Suyue; J I Zhong Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2020-01-30